Showing 12 search results
Unique caprylate/chromatography fractionation and purification process with maximum percentage of IgG ≥98%
What is maximum purity of IgG?
Unique caprylate/chromatography fractionation and purification process with maximum percentage of IgG ≥98%
Gamunex Connexions offers financial help for your patients and administrative help for your office.
Gamunex Connexions Support Program for CIDP Patients
Gamunex Connexions offers financial help for your patients and administrative help for your office.
Several mechanisms play a role in the pathophysiology of CIDP, including inflammation, demyelination, and axonal damage.
Several mechanisms play a role in the pathophysiology of CIDP, including inflammation, demyelination, and axonal damage.
The ICE study established the standard for dosing IVIG in CIDP with 87% of loading dose courses given over 2 days.
Dosing and Administration for GAMUNEX-C
The ICE study established the standard for dosing IVIG in CIDP with 87% of loading dose courses given over 2 days.
Trusted neuroprotection from inflammation in CIDP with >87% of responders relapse free in the extension phase of the ICE study.
Trusted neuroprotection from inflammation in CIDP with >87% of responders relapse free in the extension phase of the ICE study.
Trusted neuroprotection from inflammation in CIDP with >87% of responders relapse free in the extension phase of the ICE study.
Trusted neuroprotection from inflammation in CIDP with >87% of responders relapse free in the extension phase of the ICE study.
Several mechanisms play a role in the pathophysiology of CIDP, including inflammation, demyelination, and axonal damage.
Chronic inflammatory demyelinating polyneuropathy is complex
Several mechanisms play a role in the pathophysiology of CIDP, including inflammation, demyelination, and axonal damage.
The ICE study established the standard for dosing IVIG in CIDP with 87% of loading dose courses given over 2 days.
Dosing and Administration for GAMUNEX-C
The ICE study established the standard for dosing IVIG in CIDP with 87% of loading dose courses given over 2 days.
GAMUNEX-C fights inflammation, has proven tolerability, and reduces the impact of CIDP on patients' lives.
GAMUNEX-C fights inflammation, has proven tolerability, and reduces the impact of CIDP on patients' lives.
Coverage authorization, billing, coding, reimbursement, and storage and handling of GAMUNEX-C
Office Resources and Support for CIDP
Coverage authorization, billing, coding, reimbursement, and storage and handling of GAMUNEX-C